Navigation Links
Outcomes for cardiac valve procedure patients are affected by insurance status
Date:7/6/2011

redictor of disease and the differences in allocation of surgical treatment as a function of payer status, no study has fully examined the impact of primary payer status among patients undergoing cardiac valve procedures, nor have they been evaluated in a national database.

The study evaluated 477,932 patients undergoing cardiac valve operations over a six-year period using discharge data from the Nationwide Inpatient Sample database. Patients in each payer group had different demographics; income and risk factors, and risk adjustment identified the independent effect of payer status.

After adjusting for risk factors, payer status remained a highly significant predictor of mortality. Specifically, uninsured, Medicaid, and Medicare status showed a 100 percent, 70 percent, and 36 percent increase in the odds of in-hospital death, respectively, compared with private insurance. A review of multiple variables for postoperative complications identified uninsured, Medicaid and Medicare payer status as important independent predictors of morbidity as well.


'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Page: 1 2

Related biology news :

1. Giving up smoking averts the adverse birth outcomes associated with tobacco
2. Study reveals that financial conflicts of interest are associated with positive study outcomes
3. Targeted adalimumab treatment can optimize long-term outcomes for patients with early RA
4. Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest
5. Physical health scores predict breast cancer outcomes
6. Some outcomes of the evolutionary race buck conventional wisdom
7. Researchers identify biomarkers of poor outcomes in preemies
8. Unique needs and outcomes of pregnant women with breast cancer identified
9. New cochlear implant could improve outcomes for patients
10. Smoking during radiation therapy for head and neck cancers linked to poorer outcomes
11. Disparities persist in outcomes for African-American women with advanced breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... published new research from Bjorn Brembs, professor of neurogenetics ... with a proof-of-concept figure allowing readers and reviewers to ... This represents an important leap forward for scientific publishing, ... quality of a scholarly output. , Figure 3 in ... and their code to F1000Research , and the ...
(Date:7/30/2014)... therapies for spinal cord injury (SCI), traumatic brain injury ... great deal has been learned over the past 30 ... factors that regulate axon growth, but this large body ... therapeutics. Prof. Lemmon and his team from University of ... root causes, but a consensus is emerging that one ...
(Date:7/30/2014)... a paper published online today in the journal ... researchers Evan Kodra and Auroop Ganguly found that while ... variability in temperature extremes. For instance, while each year,s ... averages will also tend to fall within a wider ... are currently being observed. This means that even as ...
Breaking Biology News(10 mins):F1000Research brings static research figures to life 2Big data confirms climate extremes are here to stay 2
... 11, 2013 Elsevier, a world-leading provider of scientific, ... launch of Journal of Forensic Radiology and Imaging ... the International Society of Forensic Radiology and Imaging (ISFRI). ... of forensic radiology and imaging, JOFRI aims ...
... Discovery , the flagship journal of the American Association ... American research centres, presents significant results in treating cancer ... This marks the first time that the therapeutic effect ... Barcelona, 11 February 2013. A study led by Dr ...
... By thinking of cells as programmable robots, researchers at Rice ... tiny blood vessels that feed the brain and help people ... Amina Qutub and her colleagues simulate patterns of microvasculature cell ... their lab. Eventually, they want to develop the ability to ...
Cached Biology News:Elsevier announces the launch of a new journal: Journal of Forensic Radiology and Imaging 2First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment 2First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment 3Rice University lab show how blood vessels regroup after stroke 2Rice University lab show how blood vessels regroup after stroke 3
(Date:7/30/2014)... 2014 With the accelerated aging ... health expenditure as well as the improved medical ... diagnostic reagent industry has been developing quickly, especially ... 2013, Chinese in vitro diagnostics market size reached ... in vitro diagnostic reagents. , Read complete ...
(Date:7/30/2014)... Vycom announces the addition of Thermax PVC to ... Mutual (FM) 4910 fire propagation and smoke generation criteria ... tools, fume hoods, furniture and cabinetry. These criteria reduce ... used in electronic chip manufacturing. , Flametec ... workability and superior aesthetics. It is available in a ...
(Date:7/30/2014)...  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), is ... technologies are used to discover, develop, manufacture and ... bio-based chemical, biopharmaceutical and industrial enzyme industries, announced ... Vice President and Chief Financial Officer. Tom will ... technology operations for Dyadic and will succeed ...
(Date:7/30/2014)... July 30, 2014  AtheroNova Inc. (OTCBB: AHRO), ... development of compounds to safely regress atherosclerotic plaque ... that its partner, CardioNova, has accomplished first dosing ... with AtheroNova,s lead compound, AHRO-001.  This Phase 1b ... Phase 1 safety trial completed in February 2014, ...
Breaking Biology Technology:China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 3Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4
... 9 Boston Scientific,Corporation (NYSE: BSX ) ... has revised its Rating Outlook on the Company, ... long-term credit rating of,BB+., Fitch said the ... is making toward stabilizing its drug-eluting stent and ...
... Pressure,BioSciences, Inc. (Nasdaq: PBIO ) ("PBI") ... (PNNL), the Harvard School of,Public Health (HSPH), the ... Drug Administration (FDA) presented data generated through the,use ... last week,s,(June 1-5) American Society for Mass Spectrometry,s ...
... Inc. (Nasdaq:,NUVA), a medical device company focused on developing ... today,that Kevin O,Boyle, Executive Vice President and Chief Financial ... Annual Growth Stock,Conference at the Four Season Hotel, Chicago, ... A live Web cast of the presentation will ...
Cached Biology Technology:Boston Scientific Welcomes Revised Outlook From Fitch Ratings 2Boston Scientific Welcomes Revised Outlook From Fitch Ratings 3Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO 2Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO 3Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO 4NuVasive to Present at William Blair 28th Annual Growth Stock Conference 2NuVasive to Present at William Blair 28th Annual Growth Stock Conference 3
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Pendrin (H-195)...
Request Info...
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
Biology Products: